41 results on '"Towse, Adrian"'
Search Results
2. Placing a value on increased flexible vaccine manufacturing capacity for future pandemics
3. The Allocation of the Economic Value of Second-Generation Antipsychotics Over the Product Life Cycle: The Case of Risperidone in Sweden and the United Kingdom
4. Real Option Value: Should We Opt In or Out?
5. Why We Need a New Outcomes-Based Value Attribution Framework for Combination Regimens in Oncology
6. Considering Severity in Health Technology Assessment: Can We Do Better?
7. Working towards a sustainable, healthy market for vaccines: A framework to support evidence-based policymaking
8. Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations
9. How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?
10. Uncertainty and Cures: Discontinuation, Irreversibility, and Outcomes-Based Payments: What Is Different About a One-Off Treatment?
11. Specific Value Assessment Considerations
12. Affordability of New Technologies: The Next Frontier
13. Paying for Cures: Perspectives on Solutions to the “Affordability Issue”
14. Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach: An ISPOR Special Task Force Report [4]
15. Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report [5]
16. A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]
17. Time for a change in how new antibiotics are reimbursed: Development of an insurance framework for funding new antibiotics based on a policy of risk mitigation
18. Value assessment in precision cancer medicine
19. Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis
20. International Decision Support Initiative: Mapping of Priority-Setting in Health for 17 Low and Middle Countries Across Asia, Latin America and Africa
21. What is the Role of HTA for Biosimilars?
22. Comparative and Relative Effectiveness: A Challenge for Health Systems, Regulators, or Pharmaceutical Companies?
23. Economic Incentives for Evidence Generation: Promoting an Efficient Path to Personalized Medicine
24. Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force
25. Is the Link between Health and Wealth Considered in Decision Making? Results from a Qualitative Study
26. Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold
27. Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group
28. Prospective Observational Studies to Assess Comparative Effectiveness: The ISPOR Good Research Practices Task Force Report
29. The Use of Pay-for-Performance for Drugs: Can It Improve Incentives for Innovation?
30. Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
31. Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches
32. Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?
33. Incentives for R&D for New Antimicrobial Drugs
34. Net Clinical Benefit: The Art and Science of Jointly Estimating Benefits and Risks of Medical Treatment
35. New Drugs to Tackle Antimicrobial Resistance: Analysis of EU Policy Options
36. Using QALYs in Cancer: A Review of the Methdological Limitations
37. Variability of Cost-Effectiveness Estimates for Pharmaceuticals in Western Europe: Lessons for Inferring Generalizability
38. The Drug Budget Silo Mentality in Europe: An Overview
39. Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents
40. The Economics of Gene Therapy and of Pharmacogenetics
41. Is disease management relevant in Europe: some evidence from the United Kingdom
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.